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Abstract
Background: Decreased infiltration of Foxp3+ T regulatory cell (Treg) is considered to be critical
for the Th1/Th2 dysregulation of nasal polyps, while the cellular mechanism underlying Foxp3+
Treg insufficiency is currently not well defined.
Methods: We attempted to investigate the tissue expression of phosphorylated mammalian target
of rapamycin (pmTOR) and infiltration of Foxp3+ Tregs in 28 nasal polyps and 16 controls by
histological staining. We also evaluated the effects of blocking the mTOR signaling pathway with
rapamycin on T cell phenotype selection and Foxp3+CD4+ Tregs expansion in a tissue culture
system.
Results:  Significantly increased infiltration of pmTOR+ inflammatory cells and decreased
infiltration of Foxp3+CD4+ Tregs into nasal polyps was observed, with an inverse association. In
the tissue culture system, we detected significantly elevated Foxp3 expression and IL-10
production, as well as an increased percentage of Foxp3+ Tregs in nasal polyps after blocking the
mTOR signaling pathway with rapamycin.
Conclusion:  Here we demonstrate for the first time that the mTOR signaling pathway is
associated with Foxp3+ Tregs insufficiency in nasal polyps. Inhibition of the mTOR signaling
pathway may be helpful for enhancement of Foxp3+ Treg expansion, as well as modulation of T cell
phenotype imbalances in nasal polyps.
Background
Chronic rhinosinusitis is generally classified as chronic
rhinosinusitis without nasal polyps (CRSnNP) or with
nasal polyps (CRSwNP) [1]. CRSwNP is characterized by
polyp formation and mixed types of Th1/Th2 infiltrates
and their corresponding cytokine secretions [2,3]. There is
also evidence that CRSwNP display a Th2-skewed inflam-
matory response with high levels of IL-5 and IgE [4]. At
present, an imbalanced Th1/Th2 network is thought to
play a critical role in the development of nasal polyps.
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However, the intercellular mechanisms underlying exces-
sive T helper cell infiltration into nasal polyps have not
been characterized.
Given the crucial role of T regulatory cell (Treg) in
immune regulation, it is important to investigate their
role in the pathogenesis of CRSwNP. Currently, at least
two types of CD4+ Tregs have been partially characterized
in humans: naturally occurring CD4+CD25+ Tregs and
adaptive IL-10+/TGF-β+ CD4+ Tregs [5]. Naturally occur-
ring CD4+CD25+ Tregs comprise a small proportion of
CD4+ cells in mice and humans. The most specific
biomarker of naturally occurring CD4+CD25+ Tregs is
believed to be forkhead box P3 (Foxp3), a transcription
factor that confers the regulatory phenotype to T cells [6].
There is increasing evidence that reduced Foxp3 gene
expression or impaired Foxp3 function is potentially
responsible for the development of autoimmunity and
other diseases [7].
In our previous study, we observed that the expression of
Foxp3 mRNA was downregulated in allergic rhinitis and
nasal polyps [8,9], and treatment with a topical steroid
enhanced the expression of Foxp3 mRNA and increased
Treg accumulation in nasal polyps [10]. Similarly, Van
Bruaene et al. recently demonstrated in a Western popula-
tion with CRSwNP that decreased Foxp3 mRNA expres-
sion was accompanied by upregulated T-bet and GATA-3
mRNA, and downregulated TGF-β1 protein [11].
Together, these results provide evidences that decreased
infiltration of Foxp3+ Tregs or Treg insufficiency is essen-
tial for dysregulation of the Th1/Th2 cytokine network in
nasal polyps.
The potent ability of Foxp3+ Tregs to suppress immune
responses has generated interest in harnessing their thera-
peutic potential to treat human diseases [7,12]. However,
the signaling pathway underlying Foxp3+ Tregs expansion
in humans has not been well characterized. Recent
research has demonstrated that inhibition of the mamma-
lian target of rapamycin (mTOR) is capable of fostering
the selective survival and expansion of Foxp3+ Tregs [13].
mTOR is an evolutionarily conserved 289 kDa serine/
threonine protein kinase that is inhibited by rapamycin
[14]. In mammalian cells, mTOR integrates environmen-
tal cues such as nutrients, energy, and growth factors, and
regulates cell growth and proliferation [15,16]. Most
growth factors activate mTOR in a phosphoinositide-3-
kinase (PI3K)-Akt-dependent fashion. In the presence of
rapamycin, the PI3K-Akt-mTOR signaling pathway is
inhibited, and multiple downstream targets of mTOR,
such as 4E-BP1, are dysfunctional. We hypothesized that
a hyper-activated mTOR signaling pathway contributes to
Foxp3+ Treg insufficiency in nasal polyps. Therefore, the
mTOR signaling pathway is a potential therapeutic target
for Treg restoration.
To address this issue, we analyzed the protein expression
of phosphorylated mTOR and Foxp3 in nasal polyps. We
also evaluated the effects of rapamycin stimulation on the
percentages of Foxp3+ Tregs and on the phosphatase and
tensin homologue deleted on chromosome 10 (PTEN)/
PI3K-Akt-mTOR signaling pathway in cultured nasal pol-
yps. Our investigation may help to elucidate the patho-
genesis of nasal polyps and provide an important strategy
for modulating immune dysregulation by taking advan-
tage of in situ Treg expansion in nasal polyps.
Materials and methods
Study subjects
Twenty-eight patients with CRSwNP were included in this
study. Diagnosis of CRSwNP was based on clinical his-
tory, anterior rhinoscopy, nasal endoscopy, and paranasal
CT scans. The patients met the criteria for CRSwNP
according to the American Academy of Otolaryngology-
Head and Neck Surgery Chronic Rhinosinusitis Task Force
[1]. The presence of sinusitis or bilateral nasal polyps was
confirmed by endoscopic inspection and CT scans. Polyps
were graded according to the size and extent in both the
left and right nasal fossa on a scale of 0 to 3. CT scans were
graded by the Lund-Mackay staging system [17]. Atopic
status was evaluated by a positive skin prick test (SPT) to
at least one common inhalant allergens, including house
dust mites, cat, dog, mixed cockroaches, and mixed
molds. All patients had no history of asthma or other dis-
eases. These CRSwNP patients were refractory to medical
treatments (oral antibiotics, topical steroids, decongest-
ants, and mucolytic agents for longer than six weeks), and
had undergone endoscopic sinus surgery. Patients with a
single polyp (antrochoanal, sphenochoanal) or with
other diseases correlated with nasal polyps, such as cystic
fibrosis, primary ciliary dyskinesia, and fungal rhinosi-
nusitis, were excluded from the study. The use of local or
systemic steroids or other medications was stopped at
least four weeks before endoscopic sinus surgery. Sixteen
patients with septum deviations were recruited as a con-
trol group. These subjects had no history of other respira-
tory pathology or allergy. They showed negative SPT to
common inhalant allergens, such as house dust mites and
mold. More detailed characteristics of the subjects are
included in Table 1. This study was approved by the local
institutional Ethics Committee and informed consent was
obtained from all subjects.
During surgery, polyp specimens and the inferior tur-
binate were sampled from CRSwNP patients and control
subjects, respectively. Each specimen was divided into two
portions. One portion was fixed in 4% paraformaldehydeRespiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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and embedded in paraffin for further staining. The other
portion was used immediately for nasal tissue culture.
Immunohistochemistry
The immunoactivity of pmTOR was examined in all spec-
imens using the avidin-biotin-peroxidase method accord-
ing to our previous protocol. Briefly, paraffin sections (4
to 5 μm) were deparaffinized and rehydrated. Slides were
incubated in 0.3% H2O2 for 10 min to eliminate the
endogenous peroxidase. Specimens were heated for 10
min in 10 mM citrate buffer (pH 6.0) in a pressure cooker
for epitope retrieval. Subsequently, the tissues were incu-
bated with 10% bovine serum albumin for 1 h to block
non-specific binding, followed by an overnight incuba-
tion at 4°C in the presence of a rabbit monoclonal anti-
body specific for pmTOR (Cell Signaling, Danvers, MA) at
a dilution of 1:100. Each section was incubated with a sec-
ondary antibody (biotinylated goat anti-rabbit IgG,
Zhongshan, Beijing, China), and then incubated with a
horseradish peroxidase-labelled streptavidin complex
(Zhongshan). The distribution of peroxidase was revealed
by incubating the sections in a solution containing 3% 3,
3-diaminobenzidine tetrahydrochloride before counter-
staining with hematoxylin. Negative control studies were
performed by using isotype matched IgG or by omitting
the incubation with the primary antibody according to the
preliminary experiment, where isotype matched IgG
experiment demonstrated no immunolabelling above
background.
The sections were coded and analyzed under a light
microscope with an eyepiece graticule. The number of
pmTOR-positive (pmTOR+) cells in the epithelium and
submucosae in 1 mm2 of tissue was independently evalu-
ated from ten reticules (10 × 0.1 mm2) randomly selected
from a single section by two blinded investigators. A total
of five sections per sample were examined.
Double immunofluorescence staining
Cryostat sections (4 to 5 μm in thickness) were deparaffi-
nized and rehydrated, blocked in 10% bovine serum albu-
min for 1 h, and incubated with primary antibodies
overnight at 4°C. The primary antibodies included goat
anti-human CD4 (1:100) and mouse anti-human Foxp3
(1:100). After rinsing, sections were incubated with sec-
ondary antibodies. First, a FITC-labelled donkey anti-goat
antibody specific for CD4 (1:100) was incubated with the
tissue sample for 1 h at room temperature. The Texas red-
labelled donkey anti-mouse antibody for Foxp3 (1:100)
was then incubated with the sample for 1 h at room tem-
perature. After washing with PBS and nuclear staining
with 4', 6-diamidino-2-phenylindole, dihydrochloride
(DAPI, Santa Cruz), the slides were coverslipped with
antifade reagent (Life Technologies, Rockville, MD). Neg-
ative control slides were prepared by omitting the primary
antibody. Antibodies and DAPI were purchased from
Santa Cruz Biotechnology, CA, U.S.A.
Nasal submucosal areas excluding glands below the base-
ment membrane were viewed to quantify positive cells
with an Olympus BX60 microscope (Olympus Optical
Co, Japan) and the appropriate filter sets by two blinded
investigators. Positive cells for CD4, Foxp3, and double-
positive cells for CD4/Foxp3 were counted. Results were
expressed as the number of positive cells and as the
number of double-positive cells per mm2.
Nasal tissue culture
Nasal tissue was rinsed three times with PBS containing
antibiotics (50 IU/mL penicillin and 50 μg/mL streptomy-
cin; Sigma-Aldrich, St.Louis, MO), and sectioned into
multiple samples, as described elsewhere [18]. Tissue
samples were weighed and each 100 mg section was cut
into 1 to 2 mm3-large specimens, and placed in 1 ml of
RPMI 1640 medium supplemented with 10% fetal calf
serum (Life Technologies). The nasal tissues (control infe-
rior turbinate, n = 16; nasal polyps, n = 28) were divided
and either stimulated with 10 nM rapamycin (Sigma-
Aldrich) or vehicle. All tissues were subsequently cultured
at 37°C with 5% CO2 in humidified air for 48 h.
Table 1: Characteristics of patients with CRSwNP and control subjects
Groups CRSwNP Control
Number 28 16
Sex(Male:Female) 16:12 8:8
Age(years) 37.7 ± 9.5(22~56) 34.7 ± 11.2(25~47)
Duration of disease (years) 3.4 ± 1.1(0.9~4.7) NA
Skin prick test-positive 9/28 NA
Smoking 11/28 NA
Asthma in history and present NA NA
Aspirin intolerance NA NA
CT score (Lund-Mackay) 13.5 ± 2.7 NA
Total polyps scores 4.7 ± 1.1 NARespiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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Supernatants and tissues were separated by centrifugation
and collected for further study. All supernatants were ana-
lyzed by ELISA. Nasal tissues were randomly divided into
two groups; some (control inferior turbinate, n = 9; nasal
polyps, n = 15) were used for real time RT-PCR and immu-
noblot analyses, while others (control inferior turbinate,
n = 7; nasal polyps, n = 13) were used for flow cytometric
analysis.
Real time reverse transcription polymerase chain reaction 
(RT-PCR)
Nasal tissues were collected by centrifugation and stored
at -80°C until analysis. Real-time RT-PCR was performed
as previously described [8]. RNA was extracted from nasal
tissues using TRIzol reagent (Life Technologies) according
to the manufacturer's instructions. Reverse transcription
(RT) was performed, and cDNA was synthesized from 2
μg of total RNA using an oligo (dT)18 primer and M-MLV
reverse transcriptase (TAKARA, Syuzou, Shiga, Japan).
mRNA expression was determined using an ABI PRISM
7300 Detection System (Applied Biosystems, Foster City,
CA) and SYBR Premix Taq™ (TAKARA). The sequences of
the primers were as described elsewhere [19]: T-bet
(NM_013351) forward: 5'-GAT GTT TGT GGA CGT GGT
CTT G-3'; T-bet reverse: 5'-CTT TCC ACA CTG CAC CCA
CTT-3'; GATA-3 (NM_002051) forward: 5'-GCG GGC
TCT ATC ACA AAA TGA-3'; GATA-3 reverse: 5'-GCT CTC
CTG GCT GCA GAC AGC-3'; Foxp3 (NM_014009) for-
ward: 5'-GAG AAG CTG AGT GCC ATG CA-3'; Foxp3
reverse: 5'-AGG AGC CCT TGT CGG ATG AT-3' ; RORγt
(NM_001001523) forward: 5'-TGA GAA GGA CAG GGA
GCC AA-3'; RORγt reverse 5'-CCA CAG ATT TTG CAA
GGG ATC A-3'; β-actin (NM_001101) forward: 5'-AAG
ATG ACC CAG ATC ATG TTT GAG ACC-3'; β-actin reverse
5'-AGC CAG GTC CAG ACG CAG GAT-3'. PRISM samples
contained 1 × SYBR Green Master Mix, 1.5 μL of 5 μM
primers, and 25 ng of synthesized cDNA in a 25-μL vol-
ume. Reactions were heated to 95°C for 10 min, followed
by 40 cycles of denaturation at 95°C for 10 s, and anneal-
ing extension at 60°C for 60 s. All PCR reactions were per-
formed in duplicate. A melting curve analysis was used to
control for amplification specificity. Routine PCR was per-
formed and PCR products were analyzed with 1.5% agar-
ose gel electrophoresis in the presence of ethidium
bromide for UV light transilluminator visualization to
confirm the expected size. The expression of the target
gene was expressed as a fold increase or decrease relative
to the expression of β-actin. The mean value of the repli-
cates for each sample was calculated and expressed as a
cycle threshold (Ct). The level of gene expression was cal-
culated as the difference (ΔCt) between the Ct value of the
target gene and the Ct value of β-actin. Fold changes of
mRNA in nasal tissues were normalized to controls and
determined as 2-ΔΔCt .
Flow Cytometric Analysis
Nasal tissues were collected after centrifugation, cut into
small fragments, and teased apart to allow dispersion of
the nasal cells into RPMI 1640. The cells were passed
through a 40 μm mesh to obtain a single cell suspension.
Following a rinse, cells were adjusted maximally to 2 × 106
cells/ml and labeled with the following anti-human
mAbs: FITC conjugated CD4, APC conjugated CD25, and
PE conjugated Foxp3 (eBioscience, San Diego, CA). Cell
labelling was performed according to the manufacturer's
instructions. Specifically, intracellular Foxp3 stain was
labelled after prepared fixation/permeabilization buffer
(eBioscience) was used. Cell fluorescence was measured
using a FACSCalibur flow cytometer (BD Biosciences, San
Diego, CA), and data were analyzed using CellQuest soft-
ware (BD Biosciences).
Western blotting
Nasal tissues were collected by centrifugation, lysed, and
then stored at -80°C until analysis. The protein concentra-
tion was determined by the Bradford method. Samples
containing 5 μg of protein were boiled and subjected to
sodium dodecyl sulfate polyacrylamide gel electrophore-
sis in 10% Tris-glycine gels, and then transferred electro-
phoretically to a polyvinylidene fluoride membrane. The
membrane was incubated with 5% non-fat milk in Tris
buffered solution (TBS) containing 0.05% Tween 20 (1 h,
room temperature) and incubated (overnight, 4°C) with
anti-human monoclonal antibodies, including PTEN,
PI3K, pAkt, pmTOR, p4E-BP1 (Cell Signaling) and T-bet,
GATA-3, Foxp3, and β-actin (Santa Cruz), at different
dilutions (1:1000 to 1:4000). The membrane was washed
twice with TBS containing 0.05% Tween 20 and incubated
with horseradish peroxidase-linked secondary antibodies
(1:1000 to 1:4000). The immunoreactivity of proteins in
the membrane was determined using an ECL chemilumi-
nescence reaction kit, followed by exposure to medical
film according to the manufacturer's instructions. The rel-
ative band density of the target protein to β-actin was
quantified with Bio-Rad Quantity One 1-D Analysis Soft-
ware (Bio-Rad, CA, USA).
Enzyme-linked immunosorbent assay (ELISA)
The contents of cytokines in culture supernatants were
determined by ELISA. The levels of IFN-γ, IL-4, IL-5, and
IL-10 in the supernatants were determined using cytokine-
specific ELISA kits (Bios, Beijing, China) according to the
manufacturer's instructions. The sensitivity of the ELISA
assay for cytokines was as follows: IFN-γ, 15.6 pg/ml; IL-4,
3.2 pg/ml; IL-5, 3.2 pg/ml; IL-10, 7.8 pg/ml. Assays were
performed in duplicate. Results are expressed in pg/ml.
Statistical analysis
Data are expressed as means ± SEM. The unpaired Stu-
dent's t test for intergroup comparisons was applied forRespiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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histologic examination and the quantitative relationship
between the numbers of pmTOR+ inflammatory cells and
Foxp3+CD4+ cells was assessed by linear regression. To
evaluate tissue culture assay, a one-way ANOVA test and
Bonferroni correction were applied for multiple compari-
sons, followed by a paired or unpaired Student's t-test for
intragroup comparison. A P value less than 0.05 was con-
sidered as statistically significant.
Results
Increased pmTOR expression in nasal polyps by 
immunohistochemistry
In order to determine the phosphorylation status of
mTOR in nasal tissues, pmTOR expression was examined
by immunohistochemistry (Figure 1A, B, C, D) and
pmTOR+ cells in the epithelium and submucosa (repre-
senting inflammatory cells) were quantified (Table 2). We
found that cytoplasmic pmTOR immunostain was prima-
rily located in subepithelial inflammatory cells. Addi-
tional stain was also detected in the pseudostratified
ciliated columnar epithelium of the nasal mucosa. The
number of pmTOR+ cells was significantly higher in the
submucosa (P < 0.01 by unpaired t-test) and the epithe-
lium of nasal polyps (P < 0.05 by unpaired t-test) com-
pared to that in the control mucosa. Therefore, we provide
evidence for significantly elevated infiltration of pmTOR+
cells into nasal polyps.
Decreased Foxp3+CD4+ Tregs in nasal polyps by double 
immunofluorescence
In general, Foxp3 is thought to be a specific biomarker of
naturally occurring Tregs, although it is also present in
other non-CD4+ cells. In order to more precisely identify
Foxp3+ Tregs in nasal polyps, we simultaneously evalu-
ated CD4 and Foxp3 by double immunofluorescence
staining. We observed that more than 80% of Foxp3 was
located in CD4+ T cells based on overlaid double immun-
ofluorescence stains. Representative slides of overlaid
Foxp3+CD4+ cells in nasal tissues are shown in Figure 1E
and Figure 1F. As shown in Table 2, the number of
Foxp3+CD4+ cells decreased significantly in nasal polyps
compared to control nasal tissues (P  < 0.05 by the
unpaired  t-test). In order to evaluate whether
Foxp3+CD4+ cells were associated with pmTOR+ inflam-
matory cells, we investigated the quantitative relationship
between the numbers of pmTOR+ inflammatory cells and
Foxp3+ CD4+ Tregs in nasal polyps by linear regression.
Our results indicate that the number of Foxp3+CD4+
Tregs negatively correlated with the number of pmTOR+
inflammatory cells in nasal polyps (b = -0.74, P < 0.01).
Rapamycin modulates the gene expression of T-bet, 
GATA-3, Foxp3, and RORγt in cultured nasal polyps
Since the functional development of T cells is regulated by
specific transcription factors, we quantified the levels of T-
bet, GATA-3, Foxp3, and RORγt mRNA in rapamycin-
stimulated nasal polyps by real time RT-PCR. As shown in
Figure 2, the expression of T-bet, GATA-3, Foxp3, and
RORγt mRNA was detected in all specimens, and signifi-
cant changes in T-bet, GATA-3, and Foxp3 gene expression
were observed during multiple comparisons (P < 0.0125
by the ANOVA test and Bonferroni correction). For intra-
group comparison, we observed a significant elevation of
T-bet and GATA-3 mRNA, but a significant reduction of
Foxp3 mRNA in nasal polyps compared to the control
mucosa (P < 0.05 by the unpaired t-test). After stimulation
with rapamycin at a final concentration of 10 nM for 48
h, we found that Foxp3 mRNA was increased significantly
in nasal polyps, as well as in the control (5.5-fold and 2.7-
fold, respectively) (P < 0.05 by the paired t-test), whereas
T-bet and GATA-3 mRNAs were significantly decreased in
nasal polyps (42% and 56%, respectively) (P < 0.05 by the
paired t-test). However, there was no significant change in
RORγt gene expression during multiple comparisons (P >
0.0125 by the ANOVA test and Bonferroni correction).
Therefore, our results provide evidence that rapamycin
stimulation is associated with Foxp3 mRNA expression in
nasal polyps.
Rapamycin treatment is associated with an increase in 
Foxp3+ Tregs in cultured nasal polyps
In order to evaluate the frequency of Foxp3+ Tregs in nasal
polyps after rapamycin treatment, we examined CD4,
CD25, and Foxp3 biomarkers in isolated cells from nasal
polyps by flow cytometric analysis. Significant changes in
CD4+CD25+ and Foxp3+CD4+ cells were observed by
multiple comparisons (P < 0.0125 by ANOVA test and
Bonferroni correction). For intragroup comparison, we
Table 2: Quantification of pmTOR+ cells and Foxp3+/CD4+ cells in nasal polyps (per mm2)
Control tissue Nasal polyps
pmTOR+ cells in epithelium 258 ± 78 444 ± 207 P = 0.025
pmTOR+ cells in submucosa 145 ± 59 1063 ± 490 P = 0.001
CD4+ cells in submucosa 474 ± 269 535 ± 108 P = 0.062
Foxp3+ cells in submucosa 126 ± 65 49 ± 21 P = 0.037
Foxp3+CD4+ cells in submucosa 91 ± 44 41 ± 15 P = 0.015
Nasal polyps, n = 28; control inferior turbinate, n = 16
Data were expressed as means ± SEM. P value is determined compared by the unpaired t-test.Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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Infiltration of pmTOR+ cells and Foxp3+CD4+ cell in nasal tissues by histologic examination Figure 1
Infiltration of pmTOR+ cells and Foxp3+CD4+ cell in nasal tissues by histologic examination. The number of 
pmTOR+ cells was significantly higher in nasal polyps than in controls, whereas the number of Foxp3+CD4+ cells was signifi-
cantly lower in nasal polyps than in controls. Representative images are provided and the results were analyzed by the unpaired 
t-test. (A), The pmTOR+ cells were located in both the epithelium and submucosa of nasal polyps; (B), Expression of pmTOR 
was primarily located in the submucosa of nasal polyps; (C) Immunostaining of pmTOR was localized primarily to the epithe-
lium in control tissues; (D), Negative control for pmTOR staining in nasal polyps (200× magnification). (E and F), Foxp3+CD4+ 
cells were located in nasal polyps (E) and the control tissue (F), as evidenced by double immunofluorescence (400× magnifica-
tion); CD4 FITC (green); Foxp3 Texas red (red); double-positive stain (arrow, orange).Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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found the percentages of CD4+CD25+ and Foxp3+CD4+
cells to be significantly decreased in nasal polyps com-
pared to the control (Figure 3) (P < 0.05 by the unpaired
t-test). After treatment with rapamycin, a significant
increase in the frequencies of CD4+CD25+ cells and
Foxp3+CD4+ Tregs in nasal polyps was found compared
to untreated nasal polyps (P < 0.05 by the paired t-test).
Thus, our results show that rapamycin administration is
associated with elevated Foxp3+ Tregs in cultured nasal
polyps
Inhibition of mTOR signaling by rapamycin is associated 
with enhanced Foxp3 expression in cultured nasal polyps
Phosphorylation events in the PI3K-Akt-mTOR signaling
pathway lead to the functional activity of downstream
proteins, such as 4E-BP1. In order to evaluate the possible
association between inhibition of mTOR signaling and
Foxp3+ Treg expansion, we investigated a series of pro-
teins, including PTEN, PI3K, pAkt, pmTOR, p4E-BP1, T-
bet, GATA-3, and Foxp3 in rapamycin-stimulated nasal
polyps by western blot analysis. Significant changes in the
levels of PTEN, PI3K, pAkt, pmTOR, p4E-BP1, T-bet,
GATA-3, and Foxp3 were observed by multiple compari-
sons (P < 0.0125 by the ANOVA test and Bonferroni cor-
rection). For intragroup comparison, significantly higher
Rapamycin modulates the relative levels of T-bet, GATA-3, Foxp3, and ROR Figure 2
Rapamycin modulates the relative levels of T-bet, GATA-3, Foxp3, and RORγt mRNA in cultured nasal polyps, 
as determined by real time RT-PCR. Rapamycin stimulation has been shown to be associated with the expression of 
Foxp3 mRNA in nasal polyps. Elevated T-bet and GATA-3 mRNA and decreased Foxp3 mRNA were observed in nasal polyps 
(* P < 0.05 by the unpaired t-test for intergroup comparison) (A-C). After treatment with rapamycin, Foxp3 mRNA increased 
significantly in nasal polyps as well as in controls (5.5-fold and 2.7-fold, respectively) (**P < 0.05 by the paired t-test for intra-
group comparison), whereas T-bet and GATA-3 mRNAs decreased significantly in nasal polyps (42% and 56%, respectively) 
(**P < 0.05 by paired t-test intra-group comparison). No significant changes in RORγt gene expression were found by multiple 
comparisons (D) (P > 0.0125 by the ANOVA test and Bonferroni correction).Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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Rapamycin increases the percentages of Tregs in cultured nasal polyps analyzed by flow cytometry Figure 3
Rapamycin increases the percentages of Tregs in cultured nasal polyps analyzed by flow cytometry. Representa-
tive two-dimension scatter diagrams of CD4, CD25, and Foxp3 are shown (A) and we found that rapamycin treatment is asso-
ciated with an increase in Foxp3+ Tregs in cultured nasal polyps(B). Significant changes in CD4+CD25+ and Foxp3+CD4+ cells 
were observed during multiple comparisons (P < 0.0125 by the ANOVA test and Bonferroni correction). The percentages of 
CD4+CD25+ and Foxp3+CD4+ cells significantly were decreased in nasal polyps, compared to the control (Figure 3) (*P < 
0.05 by the unpaired t-test for intergroup comparison). After treatment with rapamycin, a significant increase in the frequen-
cies of CD4+CD25+ cells and Foxp3+CD4+ Tregs was found in nasal polyps (**P < 0.05 by the paired t-test for intragroup 
comparison).Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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expressions of PI3K, pAkt, pmTOR, and p4E-BP1 and
lower expression of PTEN were observed in nasal polyps
compared to the control in the absence of rapamycin
stimulation (P < 0.05 by the unpaired t-test) (Figure 4A,
B). After rapamycin treatment, the protein levels of
pmTOR and p4E-BP1 significantly decreased in nasal pol-
yps (70% and 72% for pmTOR and p4E-BP1, respectively;
P < 0.05 by the paired t-test), as well as in the control tur-
binate (69% and 68% for pmTOR and p4E-BP1, respec-
tively;  P  < 0.05 by the paired t-test) compared to
unstimulated tissues. In contrast, the expression of PTEN,
PI3K, and pAkt were not affected by rapamycin stimula-
tion (P > 0.05 by the paired t-test). Furthermore, Foxp3
expression was significantly upregulated (3.3-fold in nasal
polyps and 2.3-fold in control tissues; P < 0.05 by the
paired t-test) after rapamycin stimulation, while T-bet and
GATA-3 expression decreased correspondingly (P < 0.05
by the paired t-test). These results are consistent with the
histological findings, and confirm that mTOR signaling
pathway is associated with Foxp3 expression and Foxp3+
Treg expansion in nasal polyps.
Rapamycin modulates the protein levels of PTEN, PI3K, pAkt, pmTOR, p4E-BP1, T-bet, GATA-3, and Foxp3 in nasal polys Figure 4
Rapamycin modulates the protein levels of PTEN, PI3K, pAkt, pmTOR, p4E-BP1, T-bet, GATA-3, and Foxp3 
in nasal polys. Representative immunoblot data are shown (A) and significant changes in the levels of PTEN, PI3K, pAkt, 
pmTOR, p4E-BP1, T-bet, GATA-3, and Foxp3 were observed by multiple comparisons (P < 0.0125 by the ANOVA test and 
Bonferroni correction) (B). Significantly higher expression of PI3K, pAkt, pmTOR, and p4E-BP1 and lower expression of PTEN 
were observed in nasal polyps (* P < 0.05 by the unpaired t-test for intergroup comparison). After rapamycin stimulation, the 
protein levels of pmTOR and p4E-BP1 significantly were decreased in nasal polyps (70% and 72% for pmTOR and p4E-BP1, 
respectively; **P < 0.05 by the paired t-test for intra-group comparison), as well as in the control turbinate (69% and 68% for 
pmTOR and p4E-BP1, respectively; **P < 0.05 by the paired t-test for intragroup comparison). In contrast, the expression lev-
els of PTEN, PI3K, and pAkt were not affected by rapamycin stimulation (P > 0.05 by the paired t-test for intragroup compari-
son). Furthermore, Foxp3 expression was significantly upregulated (3.3-fold in nasal polyps and 2.3-fold in control tissues; **P < 
0.05 by the paired t-test for intra-group comparison) after rapamycin stimulation, while T-bet and GATA-3 expression corre-
spondingly decreased (**P < 0.05 by the paired t-test for intra-group comparison).Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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Rapamycin modulates the levels of inflammatory 
cytokines in cultured nasal polyps
Given that cytokine profiles reflect committed T cell phe-
notypes, we examined the contents of different cytokines
(IFN-γ for Th1, IL-4 and IL-5 for Th2, and IL-10 for Tregs)
in supernatants of the cultured nasal tissues by cytokine-
specific ELISA and found significant changes in the levels
of IFN-γ, IL-4, IL-5, and IL-10 during multiple compari-
sons (P < 0.0125 by the ANOVA test and Bonferroni cor-
rection). For intragroup comparison, more Th1/Th2 and
less Treg cytokines was observed in polyps than in control
(Figure 5) (P < 0.05 by the unpaired t-test), confirming
that nasal polyps is characterized by mixed types of Th1/
Th2 infiltrates and their corresponding cytokine secre-
tions. After rapamycin treatment, a slight decrease in Th1
and Th2 cytokines, IFN-γ, IL-4, and IL-5 (30%, 47%, and
41%, respectively;P > 0.05 by the paired t-test), and a sig-
nificant increase in IL-10 was found in nasal polyps com-
pared to the untreated polyp tissues (4.4-fold; P < 0.05 by
the paired t-test). These findings suggest that blocking
mTOR singaling by rapamycin may enhance the function
of Foxp3+ Tregs and IL-10 production in nasal polyps.
Discussion
The choice of the Th1/Th2 lineage is important for effec-
tive immune responses to specific pathogens, while the
balance between effector T cells and Tregs is vital for
acquiring immune competence without immune pathol-
ogy and autoimmunity [20]. In CRSwNP, the relationship
between the Th1/Th2 lineage and Tregs is complex. Grow-
ing evidence suggests that nasal polyps display an imbal-
ance between the Th1/Th2 lineage and Tregs. For
Rapamycin modulates the levels of T cell cytokines in the supernatants of cultured nasal polyps, as determined by ELISA Figure 5
Rapamycin modulates the levels of T cell cytokines in the supernatants of cultured nasal polyps, as determined 
by ELISA. Significant changes were observed in the levels of IFN-γ, IL-4, IL-5, and IL-10 by multiple comparisons (P < 0.0125 
by the ANOVA test and Bonferroni correction) and Rapamycin was shown to enhance IL-10 production in nasal polyps. More 
Th1/Th2 and less Treg cytokines were demonstrated in nasal polyps (*P < 0.05 by the unpaired t-test for intragroup compari-
son). After rapamycin treatment, a slight decrease in Th1 and Th2 cytokines, IFN-γ, IL-4, and IL-5 (30%, 47%, and 41%, respec-
tively;**P > 0.05 by the paired t-test for intragroup comparison), and a significant increase in IL-10 were found in nasal polyps 
(4.4-fold; **P < 0.05 by the paired t-test for intragroup comparison).Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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example, several investigators have proposed that IFN-γ,
IL-4, and IL-5-producing lymphocytes are found in nasal
polyps, and that nasal polyps possess a mixed pattern of
Th1/Th2 cytokines [2,21]. More recently, a Th2-skewed
eosinophilic inflammation with high levels of IL-5 and
IgE was described in CRSwNP, and decreased Foxp3
mRNA was demonstrated in nasal polyps. In our previous
reports [8,9], we provided evidence that the level of Foxp3
protein and the number of Foxp3+ Tregs decreased signif-
icantly in nasal polyps. Given the critical role of Foxp3+
Tregs in immune tolerance, further investigation of the
signaling pathways underlying Foxp3+ Treg enrichment
in nasal polyps is of significant interest.
In the present study, we investigated the phosphorylation
status of mTOR in a group of Chinese CRSwNP patients
by immunohistochemistry, and the infiltration of
Foxp3+CD4+ Tregs by double immunofluorescence stain-
ing. We observed significantly elevated infiltration of
pmTOR+ cells in nasal polyps compared to controls.
Moreover, the number of Foxp3+CD4+ cells was
decreased significantly. Interestingly, we found the Treg
insufficiency was negatively associated with the enhanced
infiltration of pmTOR+ inflammatory cells. Therefore, our
results raised the possibility that the mTOR signaling
pathway may be associated with Foxp3+ Treg insuffi-
ciency in nasal polyps. To our knowledge, this is the first
report examining mTOR signal in nasal polyps.
Since Foxp3+ Tregs comprise only a small proportion of
the T cell population, it is important to investigate the
mechanism involved in Treg expansion before attempting
to harness their therapeutic potential for suppressing
immune responses and treating human diseases. Recent
studies have revealed that signaling pathways initiated by
the T cell receptor, co-stimulatory molecules, IL-2 recep-
tor, TGF- and beyond are closely associated with Foxp3
expression [22]. However, the physiological factors and
pathways initiating intracellular Foxp3 expression and
promoting its immune regulatory characteristics remain
poorly understand. Research during the past two years has
generated significant interest in the association of the
PI3K/Akt/mTOR signaling pathway with Foxp3+ Treg dif-
ferentiation [23,24]. For instance, rapamycin was capable
of promoting Foxp3+CD4+CD25+ Tregs in T cell popula-
tion in the blood [24,25]. In addition, antigen stimula-
tion of naïve CD4 T cells in the presence of mTOR
blockage by rapamycin favored their differentiation into
the Foxp3+ phenotype, and these cells can participate in
mediating antigen-specific tolerance [26,27]. These find-
ings suggested that blocking the mTOR signal may be
essential for the development of Tregs, which has poten-
tial significance in designing tolerance protocols to pre-
vent graft rejection, treat autoimmunity, or enhance
allergen-specific immunotherapy. However, little is
known about the in situ expansion of Tregs in inflamma-
tory tissues such as nasal polyps in response to blocking
the mTOR pathway.
To determine the possible role of mTOR signaling in
Foxp3+ Treg insufficiency in nasal polyps, we investigated
the percentages of Foxp3+ Tregs and cytokine profiles in a
tissue culture system after treatment with rapamycin. First,
we have validated that the levels of pmTOR and p4E-BP1
were significantly decreased (by 70% and 72% for
pmTOR and p4E-BP1, respectively) in rapamycin-treated
nasal polyps, confirming that rapamycin functioned as a
negative regulator of the mTOR pathway. Subsequently,
we examined the levels of T-bet, GATA-3, Foxp3, and
RORγt mRNA expression in cultured nasal polyps. These
transcription factors are known to direct the commitment
of four types of CD4+ T cells (T-bet for Th1, GATA-3 for
Th2, Foxp3 for Tregs, and RORγt for Th17). Interestingly,
our results, presented characteristically high levels of T-
bet/GATA-3 mRNA and low levels of Foxp3 mRNA in
nasal polyps, which is consistent with previous reports
[2,3]. After treatment with rapamycin, we found that the
level of Foxp3 mRNA was increased by as much as 5.5-
fold in nasal polyps, while the levels of T-bet and GATA-3
mRNA decreased, revealing an inverse inter-modulation
tendency. Elevated Foxp3 protein (by 3.3-fold) was con-
sistently observed in nasal polyps after rapamycin admin-
istration by western blot analysis. These findings suggest
that rapamycin corrects the dysregulated immune
response by enhancing Foxp3 production.
Given that Foxp3 is also expressed by other non-CD4+ T
cells, we evaluated the change in the Foxp3+ Treg popula-
tion in nasal polyps by flow cytometric analysis to further
support our hypothesis. We consistently found that the
percentage of Foxp3+ Tregs was decreased in nasal polyps
compared to the control tissues, confirming the possible
role of Foxp3+ Tregs in the immune imbalance of nasal
polyps. Moreover, the results for CD4, CD25, and Foxp3
biomarkers in isolated T cells by flow cytometry showed
that the frequencies of CD4+CD25+ cells and
Foxp3+CD4+ Tregs significantly increased in nasal polyps
after rapamycin stimulation. This result is extremely
important because it provides direct evidence for Treg
expansion in nasal polyps after rapamycin administra-
tion.
Furthermore, we examined the changes in T cell cytokines
in the supernatants of cultured nasal polyps. A greater
level of Th1/Th2 and a lower level of Treg cytokines were
detected in nasal polyps compared to controls, confirm-
ing that nasal polyps is characterized by mixed types of
Th1/Th2 cell infiltration and their corresponding cytokine
secretions. After rapamycin stimulation, we observed a
significant increase in IL-10 (by 4.4-fold), whereas no sig-Respiratory Research 2009, 10:13 http://respiratory-research.com/content/10/1/13
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nificant change in IFN-γ, IL-4, or IL-5 was detected. IL-10
is known as an anti-inflammatory cytokine produced by
Tregs and other cells, and is involved in the regulation of
immune responses [28]. Therefore, the IL-10 overproduc-
tion may be caused by the inhibition of the mTOR signal-
ing pathway, contributing to the balance of the Th1/Th2
network in cultured nasal polyps. However, other
cytokines were likely to be unaffected by mTOR signal
since they were not significantly changed by rapamycin
administration.
Taken together, our results demonstrate that rapamycin is
associated with selective Tregs expansion in cultured nasal
polyps. During the past few years, the mixed dysregula-
tion of Th1/Th2 in pathogenesis of nasal polyps has been
well documented, however, little is known about the
importance of Tregs in modulation of the Th1/Th2 imbal-
ance [10,11]. In conjunction with our previous reports,
we concluded that the mTOR pathway may play an essen-
tial role in the Treg insufficiency, which is characteristic of
nasal polyps. Our findings are, therefore, important
because they demonstrate the possible association
between the mTOR signaling pathway and Foxp3+ Treg
expansion in nasal polyps, which may possess clinical
potential for developing strategies of treating nasal pol-
yps.
Our study contained some flaws due to technical insuffi-
ciency. First, we adopted a tissue culture system since no
ideal in vivo and in vitro model (animal or cellular) for
nasal polyps is available at present, thus restricting our
experimental plan. Second, it is very difficult for us, as
well as other investigators, to take advantage of some reli-
able methods such as knockdown or mutant constructs to
evaluate the importance of the mTOR signal in the devel-
opment of nasal polyps. Alternatively, we used rapamy-
cin, a specific inhibitor of mTOR, in this study, and
provide evidence that blocking the mTOR signal is associ-
ated with Foxp3 expression and Foxp3+ Treg expansion in
cultured nasal polyps. Our findings suggest that the
mTOR signaling pathway may play an important role in
Foxp3+ Treg insufficiency and provide some clues about
the immunomodulation in nasal polyps. However, the
detailed mechanism underlying Treg insufficiency in
nasal polyps is still not fully understood and requires fur-
ther study.
Conclusion
Our results provide the first evidence that the activation of
the mTOR signaling pathway may play an important role
in Foxp3+ Tregs insufficiency in nasal polyps and that
blocking the mTOR signal with rapamycin is associated
with Foxp3+ Treg expansion in situ. These findings will be
beneficial for better understanding the pathogenesis of
nasal polyps, as well as for developing a novel therapeutic
strategy for future clinical management.
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